Rankings
▼
Calendar
RGEN (Repligen Corporation) Stock Financials & Earnings | Market Cap Arena
RGEN
Repligen Corporation
Mkt Cap
$7B
Healthcare
·
Medical - Instruments & Supplies
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$738M
Net Income (TTM)
$49M
EPS (TTM)
$0.85
Free Cash Flow (TTM)
$91M
Gross Margin
50.9%
Op. Margin
7.6%
Net Margin
6.6%
FCF Margin
12.4%
P/S Ratio (TTM)
9.5x
P/E Ratio (TTM)
144.0x
YoY Rev Growth
+16.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$165M
$84M
$14M
Q2 23
$159M
$80M
$19M
Q3 23
$141M
$37M
$5M
Q4 23
$156M
$68M
-$887K
Q1 24
$153M
$77M
$4M
Q2 24
$159M
$73M
$7M
Q3 24
$155M
$77M
-$8M
Q4 24
$168M
$39M
-$37M
Q1 25
$169M
$91M
$7M
Q2 25
$182M
$91M
$14M
Q3 25
$189M
$101M
$17M
Q4 25
$198M
$93M
$19M
marketcaparena.com
Revenue Breakdown
RGEN
Repligen Corporation
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
9.3x
45.6x
Q2 23
9.9x
56.7x
Q3 23
10.8x
69.9x
Q4 23
11.3x
265.1x
Q1 24
11.6x
484.9x
Q2 24
11.6x
15854.9x
Q3 24
11.3x
—
Q4 24
11.1x
—
Q1 25
10.8x
—
Q2 25
10.4x
—
Q3 25
9.9x
4050.4x
Q4 25
9.5x
144.0x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$11M
$2M
Q2 23
$34M
$25M
Q3 23
$39M
$30M
Q4 23
$29M
$18M
Q1 24
$45M
$36M
Q2 24
$42M
$35M
Q3 24
$49M
$42M
Q4 24
$39M
$32M
Q1 25
$15M
$11M
Q2 25
$29M
$21M
Q3 25
$48M
$43M
Q4 25
$26M
$17M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$9M
Q2 23
$9M
Q3 23
$9M
Q4 23
$11M
Q1 24
$8M
Q2 24
$7M
Q3 24
$7M
Q4 24
$7M
Q1 25
$4M
Q2 25
$8M
Q3 25
$5M
Q4 25
$9M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-19.9%
+3.5%
Q2 23
-23.3%
-3.2%
Q3 23
-29.7%
-7.8%
Q4 23
-16.6%
+13.6%
Q1 24
-7.4%
-1.4%
Q2 24
-0.2%
+8.2%
Q3 24
+9.7%
+19.2%
Q4 24
+7.6%
+30.3%
Q1 25
+10.4%
+8.8%
Q2 25
+14.8%
+11.3%
Q3 25
+21.9%
+5.7%
Q4 25
+18.1%
-12.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$7M
4.4%
Q2 23
$5M
3.4%
Q3 23
$6M
4.5%
Q4 23
$0
0.0%
Q1 24
$9M
5.7%
Q2 24
$9M
5.8%
Q3 24
$23M
14.9%
Q4 24
$0
0.0%
Q1 25
$0
0.0%
Q2 25
$8M
4.6%
Q3 25
$0
0.0%
Q4 25
$8M
4.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$12M
$56M
$118K
—
Q2 23
$10M
—
—
$49M
Q3 23
$11M
—
—
$56M
Q4 23
$10M
—
—
$58M
Q1 24
$11M
$61M
$817K
—
Q2 24
$10M
—
—
$56M
Q3 24
$10M
—
—
$76M
Q4 24
$12M
—
—
$60M
Q1 25
$13M
—
—
$71M
Q2 25
$14M
—
—
$71M
Q3 25
$14M
—
—
$74M
Q4 25
$12M
—
—
$63M
marketcaparena.com
Revenue Segments
Product
Royalty
Quarter
Product
Royalty
Q2 23
$159M
$36K
Q3 23
$141M
$36K
Q4 23
$155M
—
Q1 24
$151M
$36K
Q2 24
$154M
$35K
Q3 24
$155M
$37K
Q4 24
$174M
—
Q1 25
$169M
$35K
Q2 25
$182M
$37K
Q3 25
$189M
$39K
Q4 25
$198M
—
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$517M
$101M
$618M
Q2 23
$604M
$0
$604M
Q3 23
$631M
$0
$631M
Q4 23
$751M
$0
$751M
Q1 24
$781M
$0
$781M
Q2 24
$809M
$0
$809M
Q3 24
$784M
$0
$784M
Q4 24
$757M
$0
$757M
Q1 25
$697M
$0
$697M
Q2 25
$709M
$0
$709M
Q3 25
$749M
$0
$749M
Q4 25
$566M
$202M
$768M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
57M
-0.1%
Q2 23
57M
-0.3%
Q3 23
57M
+0.1%
Q4 23
56M
-2.0%
Q1 24
57M
+1.3%
Q2 24
56M
-0.2%
Q3 24
57M
+0.9%
Q4 24
56M
-1.6%
Q1 25
57M
+0.9%
Q2 25
57M
-0.1%
Q3 25
57M
+0.0%
Q4 25
57M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$467K
136
FY 15
$497K
168
FY 16
$443K
236
FY 17
$301K
470
FY 18
$359K
540
FY 19
$355K
761
FY 20
$325K
1K
FY 21
$362K
2K
FY 22
$396K
2K
FY 23
$351K
2K
FY 24
$352K
2K
FY 25
$369K
2K
marketcaparena.com